A consortium of pharmaceutical companies hopes to improve the success rate of experimental cancer therapies by getting cancer researchers to share data from clinical trials.
No takes yet. Share an insight, caveat, or question.
Yudhijit Bhattacharjee (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: